Inspirata

Carevive offers an EHR-integrated cancer care management platform designed to enhance patient outcomes throughout the cancer journey. The platform facilitates treatment planning by eliciting patient preferences, assessing clinical trial interests, and addressing physical and psychosocial issues to optimize decision-making. During active treatment, Carevive enables remote symptom monitoring through electronic patient-reported outcomes (ePROs), providing symptom self-management plans and guideline-driven pathways to improve quality of life and reduce hospital visits. Post-treatment, the platform supports continuous monitoring of patient-reported late effects and coordinates necessary care, including diagnostic tests for detecting new or recurrent cancers. Additionally, Carevive's applied analytics offer access to aggregated patient experience data for continuous quality improvement and support in oncology pragmatic research.

Omda’s oncology medication management solution, Omda Cytodose, uses clinically validated protocols and patient parameters to secure optimal and safer treatment for oncology patients. The system strengthens all aspects of medical care for cancer patients, with a holistic and coherent treatment flow between doctors, pharmacists, and nurses. Omda Cytodose provides support for all adult and pediatric cancers and is suitable for every type of medical cancer treatment, including chemotherapy, immunotherapy, hormone therapy, as well as supportive medication. Originally developed by clinicians at Norway’s leading cancer center, and launched in 2001, Omda Cytodose is widely used by healthcare regions across the Nordics, with millions of orders completed. It has a 15-year record of stability, reliability, and safety. Omda Cytodose is configured with clinically validated chemotherapy protocols based on national and international guidelines.